{"description":"The number and severity of adverse events following each treatment were evaluated at each treatment visit and at the follow-up visit up to 12 months after the last treatment.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":12,"description":"All eligible subjects who underwent laser treatments at 4±1-week intervals to the vulva with a fractional CO2 laser and maintained the protocol regimen.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":12,"seriousNumAffected":0,"seriousNumAtRisk":12,"title":"Subjects Treated With CO2RE® Treatment"}],"frequencyThreshold":"0","timeFrame":"The period of time over which adverse event data were collected is from treatment visit until 12-month follow-up (16 month post last treatment)."}